Tag: Purdue pharma

First marketed in 1996, the prescription painkiller OxyContin is widely considered the medication that ignited the opioid crisis in the United States, triggering a widespread wave of addiction due to its deceptive marketing and powerful nature. The story of this drug, its manufacturer Purdue Pharma, and the consequences of its widespread use provides a critical understanding of the public health emergency still unfolding today.

In the United States, over two million people are addicted to opioids [1.6.3]. Amid this crisis, patients with severe pain face another challenge: Is Dilaudid being discontinued, and what does this mean for jejich pain management?

In 2019, Purdue Pharma filed for Chapter 11 bankruptcy following thousands of lawsuits related to its role in the opioid crisis. This action initiated a complex legal process that has reshaped the future of the company and raised questions about **what company still makes OxyContin** and what is being done to address the opioid epidemic it helped create.

Originally synthesized in Germany in 1916, oxycodone was later patented in the U.S. by Purdue Pharma, but today, multiple companies manufacture this opioid pain reliever. Understanding **who makes oxycodone** reveals a complex history involving brand-name drugs and a shift toward a market dominated by generic alternatives.